From BioHealth Investor
Biotechnology
NEOPHARM INC [NEOL] +29.21%
CERAGENIX PHARMACUTL [CGXP.OB] +11.11%
AURIGA LABORATORIES [ARGA.OB] +10.34%
POLYMEDIX INC [PYMX.OB] +7.69%
PANACOS PHARMA INC [PANC] +7.28%
Diagnostic Substances
ASPENBIO PHARMA INC [APNB.OB] +11.78%
GENELABS TECH INC [GNLB] +7.98%
EPIX PHARMACEUTICALS [EPIX] +6.79%
AMER BIO MEDICA [ABMC] +6.56%
ORCHID CELLMARK INC [ORCH] +5.93%
Drug Delivery
DELCATH SYSTEMS INC [DCTH] +3.90%
NOVADEL PHARMA INC [NVD] +2.04%
QUIGLEY CORP THE [QGLY] +1.99%
BIOVAIL CORP [BVF] +1.80%
IOMED INC [IOX] +1.08%
Drug Manufacturers
EXEGENICS INC [EXEG.OB] +19.71%
TELIK INC [TELK] +14.26%
CORTEX PHARM INC [COR] +13.41%
DEPOMED INC [DEPO] +9.92%
NITROMED, INC. [NTMD] +4.90%
Medical Appliances & Equipment
CHAD THERAPEUTICS [CTU] +15.00%
IVIVI TECHNOLOGIES, [II] +12.80%
ASPECT MEDICAL SYS [ASPM] +9.20%
LANGER INC [GAIT] +8.56%
VIASYS HEALTHCARE [VAS] +6.43%
Medical Instruments & Supplies
ALPHATEC HOLDINGS [ATEC] +26.90%
BIOFORCE NANOSCIENCE [BFNH.OB] +11.69%
OCULUS INNOVATIVE SC [OCLS] +8.11%
ARISTOTLE CP [ARTL] +8.03%
MICROMED CARDIOVASCU [MMCV.OB] +7.14%
Medical Laboratories & Research
SPHERIX INC [SPEX] +3.14%
AETERNA ZENTARIS [AEZS] +1.94%
ERESEARCHTECHNOLOG [ERES] +1.79%
ENZO BIOCHEM INC [ENZ] +1.25%
NATL DENTEX CP [NADX] +0.52%
http://www.biohealthinvestor.com/
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
